Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists
Phase of Trial: Phase I
Latest Information Update: 27 Aug 2013
At a glance
- Drugs Resiquimod (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Apr 2013 Planned number of patients changed from 120 to 90 as reported by ClinicalTrials.gov record.